41. Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4). pii: a002584. doi:10.1101/mcs.a002584. Print 2018 Aug.Germline SDHA mutations in children and adults with cancer.Dubard Gault M(1), Mandelker D(2), DeLair D(2), Stewart CR(3), Kemel Y(3)(4),Sheehan MR(3), Siegel B(3), Kennedy J(3), Marcell V(3), Arnold A(3), Al-AhmadieH(2), Modak S(5), Robson M(3)(4), Shukla N(5), Roberts S(5), Vijai J(3)(4), TopkaS(4)(6), Kentsis A(5), Cadoo K(3)(4), Carlo M(3)(4), Latham Schwark A(1), Reznik E(6), Dinatale R(6), Hechtman J(2), Borras Flores E(2), Jairam S(2), Yang C(2),Li Y(2), Bayraktar EC(7), Ceyhan-Birsoy O(2), Zhang L(2), Kohlman W(8), SchiffmanJ(8), Stadler Z(3)(4), Birsoy K(8), Kung A(5), Offit K(3)(4), Walsh MF(3)(4)(5).Author information: (1)Graduate Education Memorial, Memorial Sloan Kettering Cancer Center and Weill Cornell Genetics, New York, New York 10065, USA.(2)Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NewYork 10021, USA.(3)Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA.(4)Niehaus Center for Inherited Cancer Genomics, Clinical Genetics Service,Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA.(5)Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York,New York 10021, USA.(6)Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York,New York 10021, USA.(7)Rockefeller University, New York, New York 10021, USA.(8)Family Cancer Assessment Clinic, Huntsman Cancer Institute, University ofUtah, Salt Lake City, Utah 84112, USA.Mutations in succinate dehydrogenase complex genes predispose to familialparaganglioma-pheochromocytoma syndrome (FPG) and gastrointestinal stromal tumors(GIST). Here we describe cancer patients undergoing agnostic germline testing at Memorial Sloan Kettering Cancer Center and found to harbor germline SDHAmutations. Using targeted sequencing covering the cancer census genes, weidentified 10 patients with SDHA germline mutations. Cancer diagnoses for thesepatients carrying SDHA germline mutations included neuroblastoma (n = 1), breast (n = 1), colon (n = 1), renal (n = 1), melanoma and uterine (n = 1), prostate (n = 1), endometrial (n = 1), bladder (n = 1), and gastrointestinal stromal tumor(GIST) (n = 2). Immunohistochemical staining and assessment of patient tumors forsecond hits and loss of heterozygosity in SDHA confirmed GIST as anSDHA-associated tumor and suggests SDHA germline mutations may be a driver inneuroblastoma tumorigenesis.Â© 2018 Dubard Gault et al.; Published by Cold Spring Harbor Laboratory Press.DOI: 10.1101/mcs.a002584 PMID: 30068732 